Page last updated: 2024-09-05

s 16020-2 and Cancer of Head

s 16020-2 has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Awada, A; Caponigro, F; Comella, G; Cupissol, D; Gedouin, D; Gérard, B; Giroux, B; Guardiola, E; Kerger, J; Lopez-Pousa, JJ; Pivot, X; Rolland, F; Schneider, M	1

Trials

1 trial(s) available for s 16020-2 and Cancer of Head

Article	Year
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carbazoles; Disease Progression; Drug Administration Schedule; Edema; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pyridines; Survival Analysis; Treatment Outcome	2003

Article

Year

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.

Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:3

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carbazoles; Disease Progression; Drug Administration Schedule; Edema; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pyridines; Survival Analysis; Treatment Outcome

2003